Varicella-Zoster Virus Reactivation After Pediatric Allogeneic Hematopoietic Stem Cell Transplantation, Single-Center Experience of Acyclovir Prophylaxis.
Galip ArıcıElif Ünal İnceErdal InceDilber Talia İleriErgin ÇiftçiFigen DoğuHalil OzdemirHasan Fatih CakmakliMehmet ErtemPublished in: Pediatric transplantation (2024)
Tailoring acyclovir prophylaxis according to pre-HCT varicella history, posttransplant CD4 T lymphocyte counts and functions, and ongoing immunosuppression may help to reduce HZ-related morbidity and mortality.